MGNX — MacroGenics Cashflow Statement
0.000.00%
Last trade - 00:00
- $251.52m
- $111.14m
- $58.75m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -152 | -130 | -202 | -120 | -9.06 |
Depreciation | |||||
Non-Cash Items | 19.6 | 20.4 | 26.8 | 23.7 | -136 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -12.9 | -14.5 | 20.3 | -2.79 | 56.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -134 | -112 | -144 | -87 | -78.2 |
Capital Expenditures | -4.29 | -5.91 | -6.2 | -3.62 | -1.76 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -75.1 | -1.88 | -30.4 | 74.3 | -78.3 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -79.4 | -7.79 | -36.6 | 70.7 | -80.1 |
Financing Cash Flow Items | — | — | — | — | 149 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 120 | 174 | 123 | 1.66 | 150 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -93.7 | 54.7 | -57.7 | -14.6 | -7.93 |